Open AccessCombined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy
Author(s) -
Ahmad M. Mansour,
ZiadF Bashshur,
TarekA Sibai,
Abla Mehio Sibai,
Rola N. Hamam
Publication year - 2011
Publication title -
oman journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.306
H-Index - 16
eISSN - 0974-7842
pISSN - 0974-620X
DOI - 10.4103/0974-620x.77656
Subject(s) - medicine , phacoemulsification , ophthalmology , bevacizumab , maculopathy , optometry , visual acuity , surgery , retinopathy , chemotherapy , diabetes mellitus , endocrinology
We investigated the visual outcome of combined phacoemulsification with intravitreal bevacizumab, in eyes with dense cataract and visually significant exudative maculopathy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom